STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic…
By D. Turner, A. Ricciuto, Ayanna E. Lewis, F. D'amico, J. Dhaliwal, A. Griffiths, D. Bettenworth, W. Sandborn, Bruce E. Sands, W. Reinisch and 10 more. Gastroenterology, 2020
2,231 citations recorded by the source corpus.
BACKGROUND The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) has proposed treatment-targets in 2015 for adult IBD patients. We aimed to update the original STRIDE statements for incorporating treatment targets in both adult and pediatric IBD. METHODS Based on a systematic review of the literature and iterative surveys of 89 IOIBD members, recommendations were drafted and modified in two surveys and two voting rounds. Consensus was reached if ≥75% of participants scored the recommendation as 7-10 on a 10-point rating scale. RESULTS In the systematic-review, 11,278 manuscripts were screened, of which 435 were included. The first IOIBD survey (n=39 on Crohn's Disease (CD) and n=36 on ulcerative colitis (UC)) identified the following targets as most important: clinical response and remission, endoscopic healing, and normalization of C-reactive protein/erythrocyte sedimentation rate and calprotectin. Fifteen recommendations were identified, of which 13 were endorsed (n=70). STRIDE-II confirmed STRIDE-I long-term targets of clinical remission and endoscopic healing and added absence of disability, restoration of quality of life and normal growth in children. Symptomatic relief and normalization of serum and fecal markers have been determined as short-term targets. Transmural healing in CD and histological healing in UC are not formal targets but should be assessed as measures of the remission depth. CONCLUSIONS STRIDE-II encompasses evidence- and consensus-based recommendations for treat-to-target strategies in adults and children with IBD. This framework should be adapted to individual patients and local resources to improve outcomes.
Subfields: Complementary and alternative medicine, Genetics, Hematology
View Paper: https://www.semanticscholar.org/paper/71f67fcebdccdaea92bd1cc4cf2d971bcdd6e6fd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. Gisbert
- G. Doherty
- Flavio Caprioli
- Nicolás Avellaneda
- María Chaparro
- Peter Kienle
- Anthony de Buck van Overstraeten
- S. Minozzi
Citations in the corpus
- ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. (2026, background): “Laparoscopic surgery is the preferred approach to patients with medically refractory UC, as it is associated with lower intra-and postoperative morbidity, faster recovery, fewer adhesions and incisional hernias, shorter hospital length of stay, improved female fecundity, and better cosmesis [EL2]”